Allegra 180 mg Aventis

£14.00

Fexofenadine 180 mg tablets by Aventis represent a widely researched third-generation H1-antihistamine compound for laboratory investigation of allergic response mechanisms and histamine receptor interactions.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Allegra 180 mg Aventis
Allegra 180 mg Aventis
£14.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications of Fexofenadine 180 mg

Fexofenadine is a third-generation H1-antihistamine compound developed by Aventis for pharmaceutical research applications. This non-sedating antihistamine demonstrates selective antagonism at peripheral H1-histamine receptors while maintaining minimal central nervous system penetration in preclinical models. Researchers at Stroid UK Shop frequently investigate fexofenadine’s mechanisms alongside other research compounds to understand histamine pathway modulation and allergic response mechanisms.

Molecular Mechanisms and Laboratory Studies

Fexofenadine exhibits high selectivity for peripheral H1-histamine receptors with minimal affinity for central receptors, making it valuable for studying selective antihistamine effects. The compound demonstrates rapid onset and sustained duration in research models, with investigators examining its pharmacokinetic profile and receptor binding characteristics. Research applications include studying allergic rhinitis mechanisms, urticaria pathways, and comparative antihistamine efficacy studies. Laboratories often examine fexofenadine alongside compounds from our fexofenadine research collection to evaluate different antihistamine classes and their respective mechanisms of action.

Specifications and Research Properties

Fexofenadine 180 mg Technical Specifications
Parameter Value
Active Compound Fexofenadine Hydrochloride
Concentration 180 mg per tablet
Manufacturer Aventis
CAS Number 83799-24-0
Molecular Formula C₃₂H₃₉NO₄·HCl
Storage Conditions Room temperature, dry environment

Research laboratories utilise this standardised 180 mg formulation for consistent dosing studies and comparative research protocols. The Aventis formulation provides reliable pharmaceutical-grade quality for laboratory investigations. Many researchers combine fexofenadine studies with investigations into selective androgen receptor modulators when examining compound interactions or developing comprehensive research protocols examining multiple receptor systems.

Laboratory Compliance and Research Applications

Investigators studying antihistamine mechanisms often incorporate fexofenadine research alongside studies involving research peptides to examine potential synergistic effects or interaction pathways in cellular models. The compound’s established pharmacological profile makes it valuable for comparative studies and mechanism validation research. Research applications span from basic histamine receptor studies to complex allergic response pathway investigations in laboratory settings.

This product is intended solely for in-vitro laboratory research purposes. Not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations and institutional guidelines when handling this research compound.

Related